BioCentury
ARTICLE | Company News

Zynaxis, ProClinical deal

April 15, 2013 7:00 AM UTC

ZNXS will sell its Cauldron Process Chemistry division to ProClinical for $850,000. Cauldron provides R&D and pilot scale bulk pharmaceutical manufacturing services. ProClinical is a contract services company specializing in clinical supplies manufacturing, packaging and distribution. ...